Fiascarelli A, Merlino G, Capano S, Talucci S, et al. Antitumor activity of the PI3K delta-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer. Breast Cancer Res Treat 2023 Mar 13. doi: 10.1007/s10549-023-06895.
PMID: 36913051